3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Health technology assessment of medical devices: current landscape, challenges, and a way forward

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical devices differ from that of drug therapies, and what innovations can be adopted to overcome the inherent challenges in medical device HTA?

          Method

          HTA Accelerator Database was used to describe the landscape of HTA reports for medical devices from HTA bodies, and a literature search was conducted to understand the growth trend of relevant HTA publications in four case studies. Another literature review was conducted for a narrative synthesis of the characteristic differences and challenges of HTA in medical devices. We further conducted a focused Internet search of guidelines and a narrative review of methodologies specific to the HTA of medical devices.

          Main body

          The evidence of HTA reports and journal publications on medical devices around the world has been growing. The challenges in assessing medical devices include scarcity of well-designed randomized controlled trials, inconsistent real-world evidence data sources and methods, device-user interaction, short product lifecycles, inexplicit target population, and a lack of direct medical outcomes. Practical solutions in terms of methodological advancement of HTA for medical devices were also discussed in some HTA guidelines and literature.

          Conclusion

          To better conduct HTA on medical devices, we recommend considering multi-source evidence such as real-world evidence; standardizing HTA processes, methodologies, and criteria; and integrating HTA into decision-making.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12962-022-00389-6.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: not found
          • Article: not found

          Real-World Evidence - What Is It and What Can It Tell Us?

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The new definition of health technology assessment: A milestone in international collaboration

            An international joint task group co-led by the International Network of Agencies for Health Technology Assessment (INAHTA) and Health Technology Assessment International (HTAi) has developed a new and internationally accepted definition of HTA. The task group, consisting of representatives of leading HTA networks, societies and global organizations, developed guiding principles for the process and followed an established consultation plan with the broader HTA community to develop the definition. The consensus achieved by the international joint task group brings the collective weight of the participating networks, societies, and organizations behind the new definition. The new definition of HTA is an historic achievement and it is offered to the current and emerging HTA world as a cornerstone reference for today and into the future.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

              The purpose of this study was to analyze the factors that influence local recurrence after radiofrequency coagulation of liver tumors. Local recurrence rate varies widely between 2% and 60%. Apart from tumor size as an important risk factor for local recurrence, little is known about the impact of other factors. An exhaustive literature search was carried out for the period from January 1, 1990 to January 1, 2004. Only series with a minimal follow-up of 6 months and/or mean follow-up of 12 months were included. Univariate and multivariate meta-analyses were carried out. Ninety-five independent series were included, allowing the analysis of the local recurrence rate of 5224 treated liver tumors. In a univariate analysis, tumor-dependent factors with significantly less local recurrences were: smaller size, neuroendocrine metastases, nonsubcapsular location, and location away from large vessels. Physician-dependent favorable factors were: surgical (open or laparoscopic) approach, vascular occlusion, general anesthesia, a 1-cm intentional margin, and a greater physician experience. In a multivariate analysis, significantly less local recurrences were observed for small size (P < 0.001) and a surgical (versus percutaneous) approach (P < 0.001). Radiofrequency coagulation by laparoscopy or laparotomy results in superior local control, independent of tumor size. The percutaneous route should mainly be reserved for patients who cannot tolerate a laparoscopy or laparotomy. The short-term benefits of less invasiveness for the percutaneous route do not outweigh the longer-term higher risk of local recurrence.
                Bookmark

                Author and article information

                Contributors
                yanwei@fudan.edu.cn
                yychen@shmu.edu.cn
                Journal
                Cost Eff Resour Alloc
                Cost Eff Resour Alloc
                Cost Effectiveness and Resource Allocation : C/E
                BioMed Central (London )
                1478-7547
                5 October 2022
                5 October 2022
                2022
                : 20
                : 54
                Affiliations
                [1 ]Real World Solutions, IQVIA, Shanghai, 200124 China
                [2 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, National Health Commission Key Laboratory of Health Technology Assessment, School of Public Health, , Fudan University, ; Shanghai, 200032 China
                Article
                389
                10.1186/s12962-022-00389-6
                9533595
                36199144
                edf44336-ae7e-4f9f-a19b-e346a4aba1fe
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 8 March 2022
                : 21 September 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100012166, National Key Research and Development Program of China;
                Award ID: No. 2018YFC1312900
                Award Recipient :
                Categories
                Review
                Custom metadata
                © The Author(s) 2022

                Public health
                health technology assessment,medical devices,challenges,real-world evidence,review
                Public health
                health technology assessment, medical devices, challenges, real-world evidence, review

                Comments

                Comment on this article